tirzepatide and chronic kidney disease What is the approach to using (glucagon-like peptide-1 (GLP-1) receptor agonist) in patients with (CKD) stage 3? Tirzepatide linked to lower risk

At our Simply Slim Medical locations in Bethesda, MD, and Tysons, VA, we create lipotropic injection treatment plans to help patients reach their goals quickly, increase their metabolism, and burn excess body fat

Schedule a consultation with Dr

Because of its therapeutic effects, pharmaceutical companies have developed drugs that mimic GLP-1s effects to treat obesity, prediabetes, and type 2 diabetes mellitus

The Step-HFpEF Trialists took 529 patients with proven HFpEF and typical heart failure symptoms (tiredness, breathlessness, limitation of physical activity) and a BMI of greater than 30kg/m2 (obese) and randomised half of them to receive the semaglutide injections and half to receive a placebo (a dummy injection) for 52 weeks

Accelerates tissue repair and post-exercise recovery

Both contain the same active ingredient (semaglutide) and work through identical mechanisms